OtherDRUG METABOLISM AND DISPOSITION
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
Josephine M. Glover, Janet M. Leeds, Timothy G. K. Mant, Dipti Amin, Daniel L. Kisner, Joan E. Zuckerman, Richard S. Geary, Arthur A. Levin and William R. Shanahan Jr.
Journal of Pharmacology and Experimental Therapeutics September 1997, 282 (3) 1173-1180;
Josephine M. Glover
Janet M. Leeds
Timothy G. K. Mant
Dipti Amin
Daniel L. Kisner
Joan E. Zuckerman
Richard S. Geary
Arthur A. Levin
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Journal of Pharmacology and Experimental Therapeutics
Vol. 282, Issue 3
1 Sep 1997
OtherDRUG METABOLISM AND DISPOSITION
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
Josephine M. Glover, Janet M. Leeds, Timothy G. K. Mant, Dipti Amin, Daniel L. Kisner, Joan E. Zuckerman, Richard S. Geary, Arthur A. Levin and William R. Shanahan
Journal of Pharmacology and Experimental Therapeutics September 1, 1997, 282 (3) 1173-1180;
OtherDRUG METABOLISM AND DISPOSITION
Phase I Safety and Pharmacokinetic Profile of an Intercellular Adhesion Molecule-1 Antisense Oligodeoxynucleotide (ISIS 2302)
Josephine M. Glover, Janet M. Leeds, Timothy G. K. Mant, Dipti Amin, Daniel L. Kisner, Joan E. Zuckerman, Richard S. Geary, Arthur A. Levin and William R. Shanahan
Journal of Pharmacology and Experimental Therapeutics September 1, 1997, 282 (3) 1173-1180;
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement